Inhibikase Therapeutics Completes Amendment to Certificate of IncorporationAtlanta, Georgia – Inhibikase Therapeutics, Inc. (NYSE:IKT) recently announced the successful completion of a Special Meeting of Stockholders on January 3, 2025. During this m
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Inhibikase Therapeutics’s 8K filing here. Inhibikase Therapeutics Company Profile (Get Free Report) Inhibikase Therapeutics, Inc, a clinical-stage pharmaceutical company, develops therapeutics for Parkinson’s disease and related disorders. Its lead product candidate is […]
More Stories
Impax Asset Management Group (LON:IPX) Sets New 12-Month Low – Here’s What Happened
Impax Asset Management Group Plc (LON:IPX – Get Free Report)’s share price hit a new 52-week low during trading on...
Biglari (NYSE:BH.A) Shares Down 7% – Time to Sell?
Biglari Holdings Inc (NYSE:BH.A – Get Free Report)’s share price dropped 7% on Tuesday . The company traded as low...
Claros Mortgage Trust (NYSE:CMTG) Reaches New 52-Week Low – Here’s Why
Shares of Claros Mortgage Trust, Inc. (NYSE:CMTG – Get Free Report) reached a new 52-week low during trading on Tuesday...
Roku (NASDAQ:ROKU) Trading Down 0.4% – Time to Sell?
Roku, Inc. (NASDAQ:ROKU – Get Free Report) fell 0.4% on Tuesday . The stock traded as low as $78.01 and...
Fast Retailing (OTCMKTS:FRCOY) Announces Quarterly Earnings Results
Fast Retailing (OTCMKTS:FRCOY – Get Free Report) posted its quarterly earnings results on Thursday. The company reported $0.29 earnings per...
Trigon Metals (CVE:TM) Sets New 12-Month Low – Here’s What Happened
Trigon Metals Inc. (CVE:TM – Get Free Report)’s share price hit a new 52-week low on Thursday . The company...